Gautam Adani’s Adani Enterprises Ltd. plans a $1.3 billion share sale via a qualified institutional placement starting as early as Oct. 7. The move follows a short-seller’s 2023 allegations of fraud, which led to a significant stock drop. The share issue aims to signal investor confidence and revive expansion efforts.
Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24
Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 15 shares,